Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AWAKE LM TT

Drug Profile

AWAKE LM TT

Alternative Names: Awake 101; Awake 102; Awake 103; AWAKE-LM-TT; Listeria tetanus toxoid; Listeria TT; Lm LLO TT

Latest Information Update: 01 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Loki Therapeutics
  • Developer Loki Therapeutics; Matter Bio
  • Class Antineoplastics; Bacterial antigens; Bacterial toxins; Immunotherapies
  • Mechanism of Action T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Adenocarcinoma; Glioblastoma; Ovarian cancer
  • Research Breast cancer; Colorectal cancer; Liver cancer; Lung cancer

Most Recent Events

  • 01 Jul 2026 AWAKE LM TT is still in preclinical phase for Ovarian cancer in USA (Loki therapeutics pipeline, July 2026)
  • 01 Jul 2026 Preclinical trials in Glioblastoma in USA (Parenteral) prior to July 2026 (Matter Bio pipeline, July 2026)
  • 10 Jun 2026 US FDA approves IND application for LM LLO TT in Adenocarcinoma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top